Article
Using Genomics to Differentiate Multiple Primaries From Metastatic Lung Cancer
16 May 2019
Abstract excerpt
INTRODUCTION: Genomic technologies present a promising mechanism of resolving the clinical dilemma of distinguishing independent primary tumors from intrapulmonary metastases in NSCLC. We evaluated the utility of discordant mapping somatic junctions from chromosomal rearrangements in diagnosing metastatic disease compared to the current standard histologic review. MATERIAL AND METHODS: Mate-pair sequencing was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
